The balance between adipogenesis and osteogenesis in bone regeneration by platelet-rich plasma for age-related osteoporosis

Biomaterials

Volumn 32, Issue 28, 2011, Pages 6773-6780

  Liu, Hen Yu ^a   Wu, Alexander T H ^b,h   Tsai, Ching Yu ^c   Chou, Kuei Ru ^c   Zeng, Rong ^d   Wang, Ming Fu ^e   Chang, Wen Chang ^a,f   Hwang, Shiaw Min ^g   Su, Ching Hua ^a   Deng, Win Ping ^c,h  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d GUANGDONG MEDICAL UNIVERSITY   (China)

^e YUANPEI UNIVERSITY   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^g FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Adipocyte; Osteoporosis; Ovariectomized senescence accelerated mice (OVX SAMP8); Platelet rich plasma (PRP); Prevention and treatment

Indexed keywords

ADIPOCYTES; OSTEOPOROSIS; OVARIECTOMIZED SENESCENCE-ACCELERATED MICE (OVX-SAMP8); PLATELET-RICH PLASMA (PRP); PREVENTION AND TREATMENT;

DISEASES; MAMMALS; MOLECULAR WEIGHT; PLASMA (HUMAN); PLATELETS;

BONE;

ADIPOGENESIS; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE REGENERATION; CELL DIFFERENTIATION; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; OVARIECTOMY; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; BLOOD TRANSFUSION; BONE DENSITY; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CELL DIFFERENTIATION; CELL LINE; CELL TRANSDIFFERENTIATION; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; OSTEOBLASTS; OSTEOGENESIS; OSTEOPOROSIS; PLATELET-RICH PLASMA;

ANIMALIA; MUS;

EID: 79960554679     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.05.080     Document Type: Article

References (35)

1. Osteoporosis prevention, diagnosis, and therapy. J Am Med Assoc 2001, 285:785-795.
2. Riggs B.L., Wahner H.W., Seeman E., Offord K.P., Dunn W.L., Mazess R.B., et al. Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest 1982, 70:716-723.
3. Raisz L.G. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005, 115:3318-3325.
4. Mundy G.R. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002, 2:584-593.
5. Devine A., Dick I.M., Dhaliwal S.S., Naheed R., Beilby J., Prince R.L. Prediction of incident osteoporotic fractures in elderly women using the free estradiol index. Osteoporos Int 2005, 16:216-221.
6. Favus M.J. Bisphosphonates for osteoporosis. N Engl J Med 2010, 363:2027-2035.
7. Mitchner N.A., Harris S.T. Current and emerging therapies for osteoporosis. J Fam Pract 2009, 58:S45-S49.
8. Miller P.D., Derman R.J. What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis?. Osteoporos Int 2010, 21:1793-1802.
9. Duque G. Bone and fat connection in aging bone. Curr Opin Rheumatol 2008, 20:429-434.
10. Duque G., Macoritto M., Kremer R. 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol 2004, 39:333-338.
11. Harada S., Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 2003, 423:349-355.
12. Maurin A.C., Chavassieux P.M., Frappart L., Delmas P.D., Serre C.M., Meunier P.J. Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. Bone 2000, 26:485-489.
13. Wan Y., Chong L.W., Evans R.M. PPAR-gamma regulates osteoclastogenesis in mice. Nat Med 2007, 13:1496-1503.
14. Schwartz A.V., Sellmeyer D.E., Vittinghoff E., Palermo L., Lecka-Czernik B., Feingold K.R., et al. Thiazolidinedione use and bone loss in older diabetic adults. J Clin Endocrinol Metab 2006, 91:3349-3354.
15. Schwartz A.V. TZDs and bone: a review of the recent clinical evidence. PPAR Res 2008, 2008:297893.
16. Lo W.C., Chiou J.F., Gelovani J.G., Cheong M.L., Lee C.M., Liu H.Y., et al. Transplantation of embryonic fibroblasts treated with platelet-rich plasma induces osteogenesis in SAMP8 mice monitored by molecular imaging. J Nucl Med 2009, 50:765-773.
17. Rosen C.J., Bouxsein M.L. Mechanisms of disease: is osteoporosis the obesity of bone?. Nat Clin Pract Rheumatol 2006, 2:35-43.
18. Wan D.C., Shi Y.Y., Nacamuli R.P., Quarto N., Lyons K.M., Longaker M.T. Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling. Proc Natl Acad Sci U S A 2006, 103:12335-12340.
19. Rosen C.J., Klibanski A. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. Am J Med 2009, 122:409-414.
20. Freymiller E.G., Aghaloo T.L. Platelet-rich plasma: ready or not?. J Oral Maxillofac Surg 2004, 62:484-488.
21. Kanno T., Takahashi T., Tsujisawa T., Ariyoshi W., Nishihara T. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation. J Oral Maxillofac Surg 2005, 63:362-369.
22. Saadeh P.B., Mehrara B.J., Steinbrech D.S., Dudziak M.E., Greenwald J.A., Luchs J.S., et al. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Phys 1999, 277:C628-C637.
23. Tang Y., Wu X., Lei W., Pang L., Wan C., Shi Z., et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 2009, 15:757-765.
24. Lucarelli E., Beccheroni A., Donati D., Sangiorgi L., Cenacchi A., Del Vento A.M., et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003, 24:3095-3100.
25. Choy L., Skillington J., Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J Cell Biol 2000, 149:667-682.
26. Joo S.S., Won T.J., Kang H.C., Lee D.I. Isoflavones extracted from sophorae fructus upregulate IGF-I and TGF-beta and inhibit osteoclastogenesis in rat bone marrow cells. Arch Pharm Res 2004, 27:99-105.
27. Muruganandan S., Roman A.A., Sinal C.J. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 2009, 66:236-253.
28. Schilling T., Kuffner R., Klein-Hitpass L., Zimmer R., Jakob F., Schutze N. Microarray analyses of transdifferentiated mesenchymal stem cells. J Cell Biochem 2008, 103:413-433.
29. Akune T., Ogata N., Hoshi K., Kubota N., Terauchi Y., Tobe K., et al. Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblasts. J Cell Biol 2002, 159:147-156.
30. Blake G.M., Griffith J.F., Yeung D.K., Leung P.C., Fogelman I. Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA. Bone 2009, 44:495-501.
31. Benglis D., Wang M.Y., Levi A.D. A comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery 2008, 62:ONS423-ONS431. discussion ONS31.
32. Zhou Y., Ni Y., Liu Y., Zeng B., Xu Y., Ge W. The role of simvastatin in the osteogenesis of injectable tissue-engineered bone based on human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 2010, 31:5325-5335.
33. Liu Y., Zhou Y., Feng H., Ma G.E., Ni Y. Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma. Biomaterials 2008, 29:3338-3345.
34. Botolin S., McCabe L.R. Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice. Endocrinology 2007, 148:198-205.
35. Bruedigam C., Eijken M., Koedam M., van de Peppel J., Drabek K., Chiba H., et al. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells 2010, 28:916-927.